[HTML][HTML] Therapeutic potential of colchicine in cardiovascular medicine: a pharmacological review

FS Zhang, QZ He, CH Qin, PJ Little, JP Weng… - Acta Pharmacologica …, 2022 - nature.com
Colchicine is an ancient herbal drug derived from Colchicum autumnale. It was first used to
treat familial Mediterranean fever and gout. Based on its unique efficacy as an anti …

Inflammation-induced thrombosis: mechanisms, disease associations and management

K Aksu, A Donmez, G Keser - Current pharmaceutical design, 2012 - ingentaconnect.com
Although inflammation-induced thrombosis is a well-known entity, its pathogenesis remains
complicated. There are complex interactions between inflammation and hemostasis …

Current concepts in the etiology and treatment of Behçet disease

C Evereklioglu - Survey of ophthalmology, 2005 - Elsevier
Behçet disease is an idiopathic, multisystem, chronic, and recurrent disease characterized
by exacerbations alternating with phases of quiescence, episodic panuveitis, and …

Short-term trial of etanercept in Behçet's disease: a double blind, placebo controlled study.

M Melikoglu, I Fresko, C Mat, Y Ozyazgan… - The Journal of …, 2005 - jrheum.org
OBJECTIVE: To determine the effect of the tumor necrosis factor-alpha blocker etanercept
on the pathergy and monosodium urate (MSU) status and on the mucocutaneous and …

Sex differences in pediatric rheumatology

M Cattalini, M Soliani, MC Caparello… - Clinical reviews in allergy & …, 2019 - Springer
Autoimmune diseases affect up to 10% of the world's population and, as a whole, they are
far more common in females, although differences exist according to the single disease and …

Behçet disease: new aspects

I Bulur, M Onder - Clinics in dermatology, 2017 - Elsevier
Behçet disease is currently considered an “autoinflammatory disease” triggered by infection
and environmental factors in genetically predisposed individuals. Although the disease is …

Efficacy of infliximab in the treatment of uveitis that is resistant to treatment with the combination of azathioprine, cyclosporine, and corticosteroids in Behçet's disease …

I Tugal‐Tutkun, A Mudun, M Urgancioglu… - … : Official Journal of …, 2005 - Wiley Online Library
Objective To investigate the effect of infliximab on the frequency of uveitis attacks and the
visual prognosis in male patients with Behçet's disease in whom uveitis was resistant to …

Anti-TNF therapy in the management of Behçet's disease—review and basis for recommendations

PP Sfikakis, N Markomichelakis, E Alpsoy… - …, 2007 - academic.oup.com
Behcet's disease (BD) is a multisystem, chronic-relapsing, inflammatory disorder classified
among the vasculitides [1, 2]. It has a worldwide distribution being more prevalent in the …

Rituximab in intractable ocular lesions of Behcet's disease; randomized single‐blind control study (pilot study)

F Davatchi, H Shams, M Rezaipoor… - … journal of rheumatic …, 2010 - Wiley Online Library
Background: Ocular lesions, the main morbidity of Behcet's disease (BD), are the most
difficult to treat. The aim of this study was to evaluate the efficacy of rituximab. Methods …

Identification of a susceptibility locus in STAT4 for Behçet's disease in Han Chinese in a genome‐wide association study

S Hou, Z Yang, L Du, Z Jiang, Q Shu… - Arthritis & …, 2012 - Wiley Online Library
Objective To identify susceptibility loci for Behçet's disease (BD) and elucidate their
functional role. Methods A genome‐wide association study (GWAS) and functional studies …